Patent ID: 6476005
Filing Date: 2002-11-05
Classification: A61K,A61L

Abstract:
An orally ingestible composition for use in mammals consisting of the following ingredients in mg/kg of bodyweight:a glucosamine salt in a range of about 2-10 mg/kg, said glucosamine salt being selected from the group consisting of hydrochloride, sulfate, nitrate, and iodide; chondroitin sulfate in a range of about 1-8 mg/kg; hydrolyzed collagen in a range of about 2-20 mg/kg; sodium hyaluronate in a range of about 1-7 mg/kg; a chelated manganese salt in a range of about 0.5-3 mg/kg; and L-malic acid in a range of about 0.2-6 mg/kg, said L-malic acid acting as a detoxifying agent.